Currently, there are 1.76B common shares owned by the public and among those 1.72B shares have been available to trade.
However, the script later moved the day high at 41.55, up 1.91%. The company’s stock has a 5-day price change of 2.53% and 4.36% over the past three months. MO shares are trading 4.34% year to date (YTD), with the 12-month market performance down to -9.41% lower. It has a 12-month low price of $39.06 and touched a high of $48.04 over the same period. MO has an average intraday trading volume of 12.28 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.42%, 0.69%, and -0.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Altria Group Inc. (NYSE: MO) shares accounts for 59.50% of the company’s 1.76B shares outstanding.
It has a market capitalization of $72.30B and a beta (3y monthly) value of 0.70. The stock’s trailing 12-month PE ratio is 9.22, while the earnings-per-share (ttm) stands at $4.57. The company has a PEG of 3.29 and a Quick Ratio of 0.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.40% over the week and 1.41% over the month.
Earnings per share for the fiscal year are expected to increase by 2.52%, and 4.15% over the next financial year. EPS should shrink at an annualized rate of 2.80% over the next five years, compared to 4.39% over the past 5-year period.
Stifel coverage for the Altria Group Inc. (MO) stock in a research note released on April 14, 2023 offered a Buy rating with a price target of $52. UBS was of a view on November 10, 2022 that the stock is Sell, while Barclays gave the stock Underweight rating on June 29, 2022, issuing a price target of $53- $36. Morgan Stanley on their part issued Equal-Weight rating on June 24, 2022.
